These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review. Wala K; Szepietowski JC Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015082 [TBL] [Abstract][Full Text] [Related]
43. Chronic kidney disease-associated pruritus (CKD-aP) is associated with worse quality of life and increased healthcare utilization among dialysis patients. Titapiccolo JI; Lonati C; Goethel-Paal B; Bello AR; Bellocchio F; Pizzo A; Theodose M; Salvador MEB; Schofield M; Cioffi M; Basnayake K; Chisholm C; Mitrovic S; Trkulja M; Arens HJ; Stuard S; Neri L Qual Life Res; 2023 Oct; 32(10):2939-2950. PubMed ID: 37269433 [TBL] [Abstract][Full Text] [Related]
44. Difelikefalin for Hemodialysis Patients with Pruritus in Japan. Narita I; Tsubakihara Y; Takahashi N; Ebata T; Uchiyama T; Marumo M; Okamura S; Gejyo F; NEJM Evid; 2023 Nov; 2(11):EVIDoa2300094. PubMed ID: 38320524 [TBL] [Abstract][Full Text] [Related]
47. The association between CKD-associated pruritus and quality of life in patients undergoing hemodialysis in Pakistan: A STROBE complaint cross-sectional study. Rehman IU; Chan KG; Munib S; Lee LH; Khan TM Medicine (Baltimore); 2019 Sep; 98(36):e16812. PubMed ID: 31490367 [TBL] [Abstract][Full Text] [Related]
48. [Pruritus in systemic diseases : Common and rare etiologies]. Kremer AE; Mettang T Internist (Berl); 2019 Aug; 60(8):814-820. PubMed ID: 31243493 [TBL] [Abstract][Full Text] [Related]
50. Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients. Solak B; Acikgoz SB; Sipahi S; Erdem T Int Urol Nephrol; 2016 Apr; 48(4):585-91. PubMed ID: 26762886 [TBL] [Abstract][Full Text] [Related]
51. Chronic Kidney Disease-Associated Pruritus, Still a Vexing Problem. Yosipovitch G NEJM Evid; 2023 Nov; 2(11):EVIDe2300227. PubMed ID: 38320532 [TBL] [Abstract][Full Text] [Related]
52. [Hemodialysis complications: focus on pruritus and vascular calcifications]. Lanot A; Urena P Nephrol Ther; 2023 Jun; 19(S1):6-14. PubMed ID: 37381741 [TBL] [Abstract][Full Text] [Related]
53. [Pruritus in systemic diseases : Common and rare etiologies]. Kremer AE; Mettang T Hautarzt; 2016 Aug; 67(8):606-14. PubMed ID: 27376752 [TBL] [Abstract][Full Text] [Related]
54. Prevalence of chronic kidney disease-associated pruritus, and association with sleep quality among hemodialysis patients in Pakistan. Rehman IU; Munib S; Ramadas A; Khan TM PLoS One; 2018; 13(11):e0207758. PubMed ID: 30496235 [TBL] [Abstract][Full Text] [Related]
55. Recent advances in the treatment of uremic pruritus. Trachtenberg AJ; Collister D; Rigatto C Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):465-470. PubMed ID: 32740217 [TBL] [Abstract][Full Text] [Related]
56. Comparing The Efficacy And Safety Of Pregabalin Vs Gabapentin In Uremic Pruritus In Patients Of Chronic Kidney Injury Undergoing Haemodialysis. Khan NJ; ; Haider S; Gilani H; Iqbal N; Ali SA; Abbasi MA J Ayub Med Coll Abbottabad; 2022; 34(3):524-527. PubMed ID: 36377169 [TBL] [Abstract][Full Text] [Related]
57. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease. Cupisti A; Piccoli GB; Gallieni M Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):71-79. PubMed ID: 31725009 [TBL] [Abstract][Full Text] [Related]
58. Relationship Between Standardized Measures of Chronic Kidney Disease-associated Pruritus Intensity and Health-related Quality of Life Measured with the EQ-5D Questionnaire: A Mapping Study. Hernandez Alava M; Sasso A; Hnynn Si PE; Gittus M; Powell R; Dunn L; Thokala P; Fotheringham J Acta Derm Venereol; 2023 Sep; 103():adv11604. PubMed ID: 37731210 [TBL] [Abstract][Full Text] [Related]